Member Info for Vertizea-Sun

What has it bought? Has anyone offered cash for the company/product? Or is it another sugar rush for day traders.

What is it about people not reading links?

Guess? My assertion is the RNS will have a £/$ sign in it because something gave the management leeway to pay the quarterly note in cash.

I'm hoping not before the first week of September as I'm planning to buy more.

They deserve each other. The clown for starting a pointless thread and Censor-in Chief for getting it deleted.

In a nod to Hemingway:

Avacta was bought out in two separate ways - slowly at first and then very quickly.

CC warned us that Simon Bennett is a busy bunny.

The most recent RNS's are full of info.

I guess CC is expecting a lot of views in the very near future. We probably won't see the extra web traffic before the bank holiday but September.......another story.

So far, so good but the problem with that theory is Darlene Deptula-Hicks. If she isn't working on the NASDAQ listing that CC did mention then why is she on the board? Any potential sale can easily be handled by Chilton & Bennett.

It's a nice idea Energyshares but I'm not convinced it will be that straightforward.

"Targeting of fibroblast activation protein (FAP) in rheumatoid arthritis patients: imaging and ex vivo photodynamic therapy"

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258553/

I'm assuming that FAP as we know it is displayed in the arthritic area and consequently pre | CISION can be effectively applied. That's a fix. Or am I misunderstanding this and Avacta intends pre | CISION to apply only to oncology?

Hopefully the promised pipeline update will indicate exactly what the statement on slide 12 of the Business Update exactly means by "broad number of diseases"

"The pre|CISION platform works exactly as designed and will have activity with tumor v. plasma cleavage other warheads in a broad number of diseases with high and mid-levels of FAP"

Good point. I've never thought about it. What's your opinion?

Slide 9 for Affimer update

https://avacta.com/wp-content/uploads/2024/06/2024-AGM-business-update-deck.pdf

Avacta has its own ADC.....Affimer Drug Conjugate.

Affimer is central to Avacta's future and that fact is clearly emphasised on slide 9 of June's Business Update:

Next-gen pre|CISION ADC therapeutics

Combining the highly tumor-specific release mechanism of pre|CISION with the biologic advantages of an Affimer create a novel class of Affimer Drug Conjugates

In September I think we'll be due an update on Simon Bennett's nine months of efforts. He's getting a shed load of money.

A licence deal would be nice.

Known as The Eggy Waltz. One step forward - two back.

Brunch

Easy Timster.... sarcasm on BB's is easily misunderstood

I don't see why CC would release meaningful news when a good part of the world is down on the beach. Contrary to received opinion a BoD doesn't have to release commercially sensitive news instantly. Market rules allow them latitude - for commercial and strategic reasons - so long as the directors don't trade the information or leak it.

The corporate suits begin to return to their desks on Monday 12th August. That'll be the start week imo.

Concerned eggy checking for signs of life.

"If #avct was an oil exploration stock it would"

In Miliband's UK it would never get a licence.